Product Information

AUSTEDO XR 48 MG TABLET is a brand product labeled by Teva Neuroscience, Inc., priced at $502.2886 per EA under NDC 68546047656. Its NADAC has been published 54 times since Jun 18, 2025.

AUSTEDO XR 48 MG TABLET

deutetrabenazine
$502.2886per EA

Strength

48 mg/1

NDC

68546047656

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

DEUTETRABENAZINE

Approval Type

New Drug (NDA)

FDA Application

NDA216354

On Market Since

5/29/2024

Price Statistics

The NADAC for AUSTEDO XR 48 MG TABLET has been published 54 times since Jun 18, 2025, and over the history we have for it it has risen 6.8%. The table below summarizes its recorded NADAC range and movement.

Current price$502.2886 per EA
All-time high$502.2886 (Jun 24, 2026)
All-time low$470.3381 (Jun 18, 2025)
52-week high$502.2886
52-week low$470.3381
Median price$474.6276
Average price$485.0880
Largest weekly change+5.5% (Jan 7, 2026)
Weeks tracked54
Tracking sinceJun 18, 2025

Price History

1W

0.0%

1M

+0.0%

3M

+0.7%

6M

+6.3%

1Y

+6.8%

3Y

N/A

5Y

N/A

All

+6.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the deutetrabenazine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of AUSTEDO XR 48 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for AUSTEDO XR 48 MG TABLET, manufactured by Teva Neuroscience, Inc., is $502.2886 per EA (NDC 68546047656), effective Jun 24, 2026.

How has the price of AUSTEDO XR 48 MG TABLET changed over time?

Over the history we have for it, the NADAC for AUSTEDO XR 48 MG TABLET has risen 6.8%. It has been tracked across 54 weekly CMS publications since Jun 18, 2025.

What are the highest and lowest recorded NADAC prices for AUSTEDO XR 48 MG TABLET?

Since Jun 18, 2025, the NADAC for AUSTEDO XR 48 MG TABLET has ranged from a low of $470.3381 (Jun 18, 2025) to a high of $502.2886 (Jun 24, 2026), with a median of $474.6276 per EA.

Are there cheaper alternatives to AUSTEDO XR 48 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AUSTEDO XR 48 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures AUSTEDO XR 48 MG TABLET?

AUSTEDO XR 48 MG TABLET (NDC 68546047656) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.